Actelion Must Pay Asahi $550M In Fasudil Suit: Jury
Actelion Ltd. on Friday was ordered by a California state court jury to pay Asahi Kasei Pharma Corp. $550 million in damages for interrupting an Asahi licensing agreement to develop hypertension...To view the full article, register now.
Already a subscriber? Click here to view full article